Biotech

All Articles

Sanofi's $80M bank on Fulcrum dystrophy medication finishes in period 3 crash

.Only 4 months after Sanofi bet $80 million in upfront cash on Pivot Therapeutics' losmapimod, the p...

Oncternal stock sinks 60% amidst discharges, test terminations

.Cancer cells company Oncternal Therapies is folding all its own medical trials as well as giving up...

Roche is actually carrying out chances that its injectable being overweight possibility might inevitably display 25% fat loss in late-stage test

.Roche is keeping out chances that its injectable being overweight possibility could ultimately disp...

Novo Nordisk hails 'exceptional' weight loss result for dual-acting dental drug in very early trial

.Novo Nordisk has elevated the top on a period 1 test of its dental amylin and also GLP-1 receptor c...

AbbVie takes legal action against BeiGene over blood cancer medicine secret method

.Just a few brief weeks after winning an FDA Fast Track tag for its investigational BTK degrader in ...

Lilly provides one-two hit along with 2nd tranche of positive records on once a week the hormone insulin candidate

.Quickly after a favorable information decline for Eli Lilly's efsitora alfa, the Indianapolis-based...

BridgeBio cuts gene treatment finances as professional data disappoint

.BridgeBio Pharma is lowering its gene therapy budget and also drawing back from the method after se...

GSK submits HSV vaccination wishes after period 2 fall short, delivering race to Moderna, BioNTech

.GSK's attempt to build the first vaccination for herpes simplex infection (HSV) has finished in fai...

GSK's long-acting breathing problem drug halved assaults in phase 3

.GSK's long-acting asthma procedure has been actually shown to halve the number of strikes in a set ...

AstraZeneca, Daiichi unbox Dato-DXd's overall survival fall short

.AstraZeneca as well as Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) has actually f...